Application no. and date | 04801138.1 (espacenet) (Federated) (European Patent Register), 20041202 | Patent/reg. no. and date | DK/EP 1708790, 20100421 | Publication date | 20061011 | Priority no. and date | US 725965, 20031202, CA 2451798, 20031202, EP 03447279, 20031202, EP 04447001, 20040105, US 752423, 20040106, EP 04447066, 20040318, CA 2461248, 20040318, US 803793, 20040318, EP 04025035, 20041021, JP 2004349085, 20041104, US 984683, 20041109, CA 2487529, 20041115 | EP pub. no. and date |
EP 1708790 20061011 | Effective date | | Applicant/owner | PharmaNeuroBoost N.V., Alkerstraat 30A
3570 Alken, BE | Applicant ref. no. | P47295DK01 | Inventor | BUNTINX, Erik, Alkerstraat 28,
B-3750 Alken, BE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 31/343 (2006.01) , A61K 31/4545 (2006.01) , A61K 31/519 (2006.01) , A61P 25/18 (2006.01) | Title | Anvendelse af pipamperon af en D2-receptorantagonist eller serotonin/dopaminantagonist til behandling af psykotiske sygdomme | Int. application no. | BE2004000172 | Int. publication no. | WO2005053796 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|